PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PEN vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PEN and LLY is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

PEN vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Penumbra, Inc. (PEN) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
37.16%
-15.94%
PEN
LLY

Key characteristics

Sharpe Ratio

PEN:

0.07

LLY:

0.52

Sortino Ratio

PEN:

0.37

LLY:

0.93

Omega Ratio

PEN:

1.04

LLY:

1.12

Calmar Ratio

PEN:

0.05

LLY:

0.67

Martin Ratio

PEN:

0.11

LLY:

1.67

Ulcer Index

PEN:

23.26%

LLY:

9.68%

Daily Std Dev

PEN:

38.43%

LLY:

31.10%

Max Drawdown

PEN:

-62.64%

LLY:

-68.27%

Current Drawdown

PEN:

-23.36%

LLY:

-24.28%

Fundamentals

Market Cap

PEN:

$10.12B

LLY:

$652.65B

EPS

PEN:

$0.87

LLY:

$9.29

PE Ratio

PEN:

303.09

LLY:

78.12

PEG Ratio

PEN:

-62.27

LLY:

0.72

Total Revenue (TTM)

PEN:

$879.10M

LLY:

$31.51B

Gross Profit (TTM)

PEN:

$539.30M

LLY:

$25.63B

EBITDA (TTM)

PEN:

-$6.00M

LLY:

$9.48B

Returns By Period

In the year-to-date period, PEN achieves a 11.04% return, which is significantly higher than LLY's -5.99% return.


PEN

YTD

11.04%

1M

10.38%

6M

38.88%

1Y

3.08%

5Y*

10.48%

10Y*

N/A

LLY

YTD

-5.99%

1M

-5.10%

6M

-15.11%

1Y

17.18%

5Y*

40.98%

10Y*

28.47%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PEN vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PEN
The Risk-Adjusted Performance Rank of PEN is 4646
Overall Rank
The Sharpe Ratio Rank of PEN is 4848
Sharpe Ratio Rank
The Sortino Ratio Rank of PEN is 4343
Sortino Ratio Rank
The Omega Ratio Rank of PEN is 4141
Omega Ratio Rank
The Calmar Ratio Rank of PEN is 4848
Calmar Ratio Rank
The Martin Ratio Rank of PEN is 4747
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 6363
Overall Rank
The Sharpe Ratio Rank of LLY is 6565
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 5858
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 5757
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 7272
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 6464
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PEN vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Penumbra, Inc. (PEN) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PEN, currently valued at 0.07, compared to the broader market-2.000.002.004.000.070.52
The chart of Sortino ratio for PEN, currently valued at 0.37, compared to the broader market-4.00-2.000.002.004.000.370.93
The chart of Omega ratio for PEN, currently valued at 1.04, compared to the broader market0.501.001.502.001.041.12
The chart of Calmar ratio for PEN, currently valued at 0.05, compared to the broader market0.002.004.006.000.050.67
The chart of Martin ratio for PEN, currently valued at 0.11, compared to the broader market-10.000.0010.0020.0030.000.111.67
PEN
LLY

The current PEN Sharpe Ratio is 0.07, which is lower than the LLY Sharpe Ratio of 0.52. The chart below compares the historical Sharpe Ratios of PEN and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
0.07
0.52
PEN
LLY

Dividends

PEN vs. LLY - Dividend Comparison

PEN has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.72%.


TTM20242023202220212020201920182017201620152014
PEN
Penumbra, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.72%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

PEN vs. LLY - Drawdown Comparison

The maximum PEN drawdown since its inception was -62.64%, smaller than the maximum LLY drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for PEN and LLY. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-23.36%
-24.28%
PEN
LLY

Volatility

PEN vs. LLY - Volatility Comparison

Penumbra, Inc. (PEN) and Eli Lilly and Company (LLY) have volatilities of 9.81% and 10.25%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%18.00%AugustSeptemberOctoberNovemberDecember2025
9.81%
10.25%
PEN
LLY

Financials

PEN vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Penumbra, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab